Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - PERNIX THERAPEUTICS HOLDINGS, INC.Financial_Report.xls
EX-4.1 - FORM OF CERTIFICATE - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_41.htm
EX-31.2 - EXHIBIT 31.2 - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_ex312.htm
EX-21.1 - EXHIBIT 21.1 - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_ex211.htm
EX-31.1 - EXHIBIT 31.1 - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_ex311.htm
EX-23.1 - CONSENT - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_ex231.htm
EX-10.17 - EXHIBIT 10.17 - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_ex1017.htm
EX-10.18 - EXHIBIT 10.18 - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_ex1018.htm
EX-10.19 - EXHIBIT 10.19 - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_ex1019.htm
10-K - FORM 10-K - PERNIX THERAPEUTICS HOLDINGS, INC.ptx_10k.htm
EXHIBIT 32.1

CERTIFICATION UNDER SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned certifies that this annual report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and that information contained in this annual report fairly presents, in all material respects, the financial condition and results of operations of Pernix Therapeutics Holdings, Inc. for the periods covered by this annual report.

Date: March 29, 2012
 
/s/ Cooper C. Collins
 
   
Cooper C. Collins
   
Chief Executive Officer and President
     
Date: March 29, 2012
 
/s/ David P. Becker
 
   
David P. Becker
   
Chief Financial Officer